Corbus Pharmaceuticals share price logo

Corbus Pharmaceuticals

NASDAQ: CRBP

$11.08

-0.38

(-3.32%)

as on

Corbus Pharmaceuticals Stock Performance

as on September 7, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $11.06
    $11.44
    downward going graph

    0.18%

    Downside

    3.25%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.12
    $20.56
    downward going graph

    35.74%

    Downside

    85.56%

    Upside

    downward going graph

Corbus Pharmaceuticals share price movements today

Previous Close
$11.46
Open
$11.36
Volume
440.1K
Market Cap
$214.3M
Day's Low - High
$11.06 - $11.44
52 Week Low - High
$7.12 - $20.56

Corbus Pharmaceuticals Historical Returns

1 Month Return
+ 8.95 %
3 Month Return
+ 46.56 %
1 Year Return
+ 12.37 %
3 Year Return
+ 56.94 %
5 Year Return
-69.73 %

Corbus Pharmaceuticals Stock Fundamentals & Key Indicators

Check Corbus Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$214.3M

EPS (TTM)

-6.19

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.71

Industry PE ratio

-1.61

PEG Ratio

0.05693334737105891

EBITDA

-101.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-87.05%

Corbus Pharmaceuticals Stock Valuation

Track how Corbus Pharmaceuticals P/E has moved over time to understand its valuation trends.

Corbus Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-3.20x)

December 31, 2024

Industry (-1.61x)

December 31, 2025

Today (-1.38x)

December 31, 2025

Highest (-0.25x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -1.38x

Corbus Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corbus Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$214.3M-69.73%-1.710.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B184.14%31.5386.04%NA
BUY$58.1B-66.65%-18.24-12.57%NA
BUY$85.2B23.76%19.7684.86%0.44999999999999996%

Stock Returns calculator for Corbus Pharmaceuticals Stock including INR - Dollar returns

The Corbus Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Corbus Pharmaceuticals investment value today

Current value as on today

₹1,20,681

Returns

₹20,681

(+20.68%)

Returns from Corbus Pharmaceuticals Stock

₹12,373 (+12.37%)

Dollar Impact

₹8,308 (+8.31%)

Analyst Recommendation on Corbus Pharmaceuticals Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Corbus Pharmaceuticals. Average target price of $34.02

Corbus Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Corbus Pharmaceuticals.

What analysts predicted

67.43%UPSIDE

Target Price

$34.02

Current Price

$11.08

Analyzed by

6 Analysts

Target

$34.02

Corbus Pharmaceuticals target price $34.02, a slight upside of 67.43% compared to current price of $11.08. According to 6 analysts rating.

Indian Investors' Interest in Corbus Pharmaceuticals Stock

Search interest for Corbus Pharmaceuticals Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Corbus Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
0
-
0
-15
0
-
-
0
-
Operating Income
-9
-10
-15
-12
-19
-19
-24
-21
-24
-36
EBITDA
-5
-9
-13
-9
-18
-17
-23
-20
-22
-34
Interest Expense
0
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
-9
-13
-9
-16
-17
-23
-20
-22
-35
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-6
-9
-13
-9
-16
-17
-23
-20
-22
-35
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Corbus Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
4
36
3
0
-
-
-
-
Gross Profit
-23
-43
-53
3
0
-1
-
0
-
Operating Income
-32
-56
-77
-122
-55
-34
-45
-48
-85
EBITDA
-32
-56
-76
-121
-42
-38
-40
-37
-78
Interest Expense
-
-
-
1
1
2
2
1
-
Depreciation
0
0
0
1
1
1
0
0
0
Income Before Tax
-32
-55
-71
-111
-45
-42
-44
-40
-78
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-32
-55
-71
-111
-45
-55
-44
-40
-78
Net Profit Margin
-967.09%
-908.11%
-147.91%
100.00%
-85.92%
0.00%
0.00%
0.00%
0.00%

Corbus Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-9
-13
-9
-16
-17
-23
-20
-22
-35
Operating Cash Flow
-7
-8
-13
-10
-16
-16
-15
-15
-25
-29
Investing Cash Flow
-98
-16
-15
8
18
17
19
-57
22
18
Financing Cash Flow
106
34
25
0
-
-
2
74
-
9
Change in Cash
0
9
-4
-2
1
1
6
1
-3
-2

Corbus Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-32
-55
-71
-111
-45
-42
-44,603
-40
-78
Operating Cash Flow
-27
-30
-45
-99
-48
-37
-36,100
-41
-64
Investing Cash Flow
0
-2
-2
0
-73
30
35,641
-121
-1
Financing Cash Flow
76
11
38
154
60
0
-2,820
166
77
Change in Cash
47
-20
-9
54
-60
-8
-3,279
3
11

Mutual Funds that own Corbus Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Corbus Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.681232%
711998
Fidelity Concord Street Trust
0.793494%
153472
DFA INVESTMENT DIMENSIONS GROUP INC
0.286945%
55499
Nationwide Mutual Funds
0.069798%
13500
T. ROWE PRICE INDEX TRUST, INC.
0.065%
12572

Global Institutional Holdings in Corbus Pharmaceuticals

Funds
Holdings
Vanguard
4.35%
iShares
3.17%
Global X
0.99%
Dimensional
0.48%
Fidelity
0.45%

Insights on Corbus Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CRBP stock has moved up by 46.6%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CRBP has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 479.0% return, outperforming this stock by 466.6%

About Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
OrganisationCorbus Pharmaceuticals
Headquarters500 River Ridge Drive, Norwood, MA, United States, 02062
IndustryBiotechnology
CEODr. Yuval Cohen Ph.D.
E-voting on sharesClick here to vote

Key Management of Corbus Pharmaceuticals

Name

Title

Dr. Leonardo Viana Nicacio M.D.

Chief Medical Officer

Dr. Yuval Cohen Ph.D.

CEO & Director

Mr. Sean F. Moran CPA, M.B.A.

Chief Financial Officer

Dr. Ian Hodgson B.Sc., Ph.D.

Chief Operating Officer

Mr. G. Scott Goeken J.D., M.S.

General Counsel & Corporate Secretary

Ms. Christina Bertsch M.A.

Vice President of Human Resources

Mr. Nishant C. Saxena

Chief Business Officer

FAQs

What is Corbus Pharmaceuticals share price today?

Corbus Pharmaceuticals share price today is $11.08 as on at the close of the market. Corbus Pharmaceuticals share today touched a day high of $11.44 and a low of $11.06.

What is the 52 week high and 52 week low for Corbus Pharmaceuticals share?

Corbus Pharmaceuticals share touched a 52 week high of $20.56 on and a 52 week low of $7.12 on . Corbus Pharmaceuticals stock price today i.e. is closed at $11.08,which is 46.11% down from its 52 week high and 55.62% up from its 52 week low.

What is Corbus Pharmaceuticals's market capitalisation today?

Corbus Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Corbus Pharmaceuticals Stock (CRBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Corbus Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corbus Pharmaceuticals Shares that will get you 0.1354 shares as per Corbus Pharmaceuticals share price of $11.08 per share as on September 7, 2026 at 8:46 am IST.

What is the minimum amount required to buy Corbus Pharmaceuticals Stock (CRBP) from India?

Indian investors can start investing in Corbus Pharmaceuticals (CRBP) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Corbus Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Corbus Pharmaceuticals share’s latest price of $11.08 as on September 7, 2026 at 8:46 am IST, you will get 0.9025 shares of Corbus Pharmaceuticals. Learn more about fractional shares .

What are the returns that Corbus Pharmaceuticals has given to Indian investors in the last 5 years?

Corbus Pharmaceuticals stock has given -69.73% share price returns and 28.66% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?